Arcus Biosciences, a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, obtained a $250 million term loan facility from Hercules Capital. The additional...
Read Story
August 28, 2024, 07:50 AM
|
B. Riley Securities led a $46.9 million financing for Radiopharm Theranostics Limited ("RAD"), an ASX listed clinical stage biotechnology company developing targeted radiopharmaceutical therapies and diagnostics for multiple types of cancer. The...
Read Story
July 03, 2024, 07:00 AM
|
Armata Pharmaceuticals, a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, entered into a secured credit agreement with Innoviva Strategic...
Read Story
March 05, 2024, 07:40 AM
|
Trinity Capital announced the commitment of $25 million in growth capital to Neuros Medical, Inc., a bioelectric technology company focused on alleviating chronic post-amputation pain and restoring quality of life. The growth capital will enable...
Read Story
November 01, 2023, 07:55 AM
|
COMPASS Pathways plc, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, entered into a term loan agreement with Hercules Capital for up to $50 million. Kabir Nath, COMPASS Pathways Chief...
Read Story
July 05, 2023, 08:00 AM
|
Aspen Neuroscience, a private biotechnology company developing autologous cell therapies including the first iPSC-derived autologous neuron replacement treatment for Parkinson's disease (PD), signed a $40 million credit facility with Silicon Valley...
Read Story
December 22, 2022, 07:34 AM
|
Gritstone bio, a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, entered into an $80 million credit facility with Hercules Capital and Silicon Valley Bank."This non-dilutive facility enhances our financial...
Read Story
July 22, 2022, 07:34 AM
|
Viridian Therapeutics, a biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies, entered into a debt financing agreement with Hercules Capital for up to $75 million. Under the...
Read Story
April 05, 2022, 07:40 AM
|
Interpace Biosciences, along with its subsidiaries, entered into a new $7.5 million revolving credit facility with Comerica Bank. The facility matures on September 30, 2023 and allows for advances based on 80% of eligible accounts receivable plus an...
Read Story
October 18, 2021, 07:09 AM
|
Kane Biotech entered into an amended and restated credit agreement with Pivot Financial dated August 31, 2021.The Amended Credit Facility amends and restates the existing credit agreement with Pivot dated November 5, 2020, increasing the credit...
Read Story
September 03, 2021, 07:11 AM
|
Radius Health announced that the Company has entered into amended and restated credit facilities in the aggregate principal amount of $175 million, consisting of a $150 million term loan, which includes a cashless conversion of $25 million in...
Read Story
March 04, 2021, 08:05 AM
|
Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, announced the closing of a $20 million senior secured term loan with VitalConnect, Inc., a leader in wearable biosensor...
Read Story
November 30, 2017, 07:05 AM
|
Fueled by a desire for innovation and new medical breakthroughs, the biotech industry continues to enjoy substantial growth due to increased investment in research and development (R&D), according to the sixth annual study from BDO USA, LLP.The 2017...
Read Story
July 17, 2017, 07:30 AM
|
T2 Biosystems, Inc., a company developing innovative diagnostic products that improve patient health and deliver a strong economic return to healthcare institutions, today announced that it has entered into a $50 million debt facility agreement with...
Read Story
January 06, 2017, 07:30 AM
|